ROYAL CRESCENT SURGERY
25 CRESCENT STREET, WEYMOUTH
CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 89 | 95 | 93.7% | |
| CKD 4 | 2008 | 205 | 232 | 88.4% | |
| CKD 5 | 2009 | 71 | 76 | 93.4% | |
| CKD 5 | 2010 | 24 | 25 | 96.0% | |
| CKD 5 | 2011 | 31 | 32 | 96.9% | |
| CKD 5 | 2012 | 35 | 36 | 97.2% | |
| CKD 5 | 2013 | 35 | 38 | 92.1% | |
| CKD003 | 2014 | 37 | 38 | 97.4% | |
| CKD003 | 2015 | 34 | 35 | 97.1% | |
| NM84 | 2016 | 29 | 36 | 80.6% | |
| NM84 | 2017 | 28 | 37 | 75.7% | |
| NM84 | 2018 | 30 | 39 | 76.9% | |
| NM84 | 2019 | 28 | 42 | 66.7% | |
| NM84 | 2020 | 29 | 40 | 72.5% | |
| NM84 | 2022 | 33 | 47 | 70.2% | |
| NM84 | 2023 | 35 | 45 | 77.8% |
